세계의 AAV 수탁 개발 및 제조 기관 시장 규모 조사 : 워크플로우별, 배양 유형별, 용도별, 최종사용자별, 지역별 예측(2022-2032년)

Global AAV Contract Development and Manufacturing Organizations Market is valued at approximately USD 621 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.85 % over the forecast period 2024-2032. The Global Market for AAV Contract Development and Manufacturing Organizations (CDMOs) focuses on the specialization of producing Adeno-Associated Virus (AAV) vectors and providing associated services that are essential for gene therapy and biopharmaceutical development. The growing need for effective AAV vector production is fueled by the rising popularity of gene therapies aimed at rare diseases and genetic disorders. Progress in biotechnology and gene editing methods has broadened the range of gene therapy, increasing the need for specialized CDMOs with AAV knowledge. Partnerships between pharmaceutical companies and CDMOs are influencing market dynamics by improving production processes and ensuring adherence to regulations. The Global AAV Contract Development and Manufacturing Market is set to experience significant growth as the healthcare sector adopts gene therapies promoting creativity and strategic collaborations in this specialized area.

The Global AAV Contract Development and Manufacturing Organizations Market is primarily driven by the increasing demand for personalized gene therapies which are tailored to individual patient's genetic profiles and medical needs. This reflects a shift towards precision medicine and targeted treatments, driving the need for specialized AAV vectors and services provided by AAV CDMOs. However, the market faces restraints related to regulatory challenges particularly concerning safety and efficacy standards for gene therapy products. These regulations require extensive testing and compliance measures contributing to the complexity and time required for the development and manufacturing processes. Despite these challenges, ongoing advancements in gene editing technologies and biopharmaceutical research continue to propel growth and innovation within the Global AAV Contract Development and Manufacturing Organizations Market.

The key regions considered for the Global AAV Contract Development And Manufacturing Organizations Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is one of the dominant regions in the Global AAV Contract Development and Manufacturing Organizations Market. North America has a significant number of top pharmaceutical and biotechnology companies that are actively engaged in gene therapy research and development. Many businesses frequently partner with AAV CDMOs to tap into their specialized knowledge and production capabilities. The region has a conducive regulatory landscape that fosters advancements in gene therapy and expedites market approvals. The rapid expansion of AAV CDMOs in North America is fueled by the region's sophisticated healthcare system and substantial investments in biopharmaceuticals. The region holds a strong influence over the Global AAV Contract Development and Manufacturing Organizations Market, leading to progress and market growth. The market in Asia Pacific, on the other hand, is expected to develop at the fastest rate over the forecast period.

Major market player included in this report are:

• Thermo Fischer Scientific, Inc.
• Creative Biogene
• Catalent Inc.
• Charles River Laboratories International, Inc.
• Danaher Corporation
• Forge Biologics
• Genezen
• ViroCell Biologics, Ltd.
• Merck KGaA
• Viralgen Vector Core S.L.

The detailed segments and sub-segment of the market are explained below:

By Workflow

• Upstream Processing
• Downstream Processing

By Culture Type

• Adherent Culture
• Suspension Culture

By Application

• Cell & Gene Therapy Development
• Vaccine Development
• Biopharmaceutical & Pharmaceutical Discovery
• Biomedical Research

By End-User

• Pharmaceutical & Biopharmaceutical Companies
• Academic & Research Institutes

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1.Global AAV Contract Development and Manufacturing Organizations Market Definition and Research Assumptions

• 1.1.Research Objective
• 1.2.Market Definition
• 1.3.Research Assumptions
  • 1.3.1.Inclusion & Exclusion
  • 1.3.2.Limitations
  • 1.3.3.Supply Side Analysis
    • 1.3.3.1.Availability
    • 1.3.3.2.Infrastructure
    • 1.3.3.3.Regulatory Environment
    • 1.3.3.4.Market Competition
    • 1.3.3.5.Economic Viability (Consumer's Perspective)
  • 1.3.4.Demand Side Analysis
    • 1.3.4.1.Regulatory frameworks
    • 1.3.4.2.Technological Advancements
    • 1.3.4.3.Environmental Considerations
    • 1.3.4.4.Consumer Awareness & Acceptance
• 1.4.Estimation Methodology
• 1.5.Years Considered for the Study
• 1.6.Currency Conversion Rates

Chapter 2.Executive Summary

• 2.1.Global AAV Contract Development and Manufacturing Organizations Market Size & Forecast (2022- 2032)
• 2.2.Regional Summary
• 2.3.Segmental Summary
  • 2.3.1.By Workflow
  • 2.3.2.By Culture Type
  • 2.3.3. By Application
  • 2.3.4. By End-User
• 2.4.Key Trends
• 2.5.Recession Impact
• 2.6.Analyst Recommendation & Conclusion

Chapter 3.Global AAV Contract Development and Manufacturing Organizations Market Dynamics

• 3.1.Market Drivers
• 3.2.Market Challenges
• 3.3.Market Opportunities

Chapter 4.Global AAV Contract Development and Manufacturing Organizations Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
  • 4.1.6.Futuristic Approach to Porter's 5 Force Model
  • 4.1.7.Porter's 5 Force Impact Analysis
• 4.2.PESTEL Analysis
  • 4.2.1.Political
  • 4.2.2.Economical
  • 4.2.3.Social
  • 4.2.4.Technological
  • 4.2.5.Environmental
  • 4.2.6.Legal
• 4.3.Top investment opportunity
• 4.4.Top winning strategies
• 4.5.Disruptive Trends
• 4.6.Industry Expert Perspective
• 4.7.Analyst Recommendation & Conclusion

Chapter 5.Global AAV Contract Development and Manufacturing Organizations Market Size & Forecasts by Workflow 2022-2032

• 5.1.Upstream Processing
• 5.2.Downstream Processing

Chapter 6.Global AAV Contract Development and Manufacturing Organizations Market Size & Forecasts by Culture Type 2022-2032

• 6.1.Adherent Culture
• 6.2.Suspension Culture

Chapter 7.Global AAV Contract Development and Manufacturing Organizations Market Size & Forecasts by Application 2022-2032

• 7.1.Cell & Gene Therapy Development
• 7.2.Vaccine Development
• 7.3.Biopharmaceutical & Pharmaceutical Discovery
• 7.4.Biomedical Research

Chapter 8.Global AAV Contract Development and Manufacturing Organizations Market Size & Forecasts by End-User 2022-2032

• 8.1.Pharmaceutical & Biopharmaceutical Companies
• 8.2.Academic & Research Institutes

Chapter 9.Global AAV Contract Development and Manufacturing Organizations Market Size & Forecasts by Region 2022-2032

• 9.1.North America AAV Contract Development and Manufacturing Organizations Market
  • 9.1.1.U.S. AAV Contract Development and Manufacturing Organizations Market
    • 9.1.1.1. Workflow breakdown size & forecasts, 2022-2032
    • 9.1.1.2.Culture Type breakdown size & forecasts, 2022-2032
    • 9.1.1.3.Application breakdown size & forecasts, 2022-2032
    • 9.1.1.4.End-User breakdown size & forecasts, 2022-2032
  • 9.1.2.Canada AAV Contract Development and Manufacturing Organizations Market
• 9.2.Europe AAV Contract Development and Manufacturing Organizations Market
  • 9.2.1.U.K. AAV Contract Development and Manufacturing Organizations Market
  • 9.2.2.Germany AAV Contract Development and Manufacturing Organizations Market
  • 9.2.3.France AAV Contract Development and Manufacturing Organizations Market
  • 9.2.4.Spain AAV Contract Development and Manufacturing Organizations Market
  • 9.2.5.Italy AAV Contract Development and Manufacturing Organizations Market
  • 9.2.6.Rest of Europe AAV Contract Development and Manufacturing Organizations Market
• 9.3.Asia-Pacific AAV Contract Development and Manufacturing Organizations Market
  • 9.3.1.China AAV Contract Development and Manufacturing Organizations Market
  • 9.3.2.India AAV Contract Development and Manufacturing Organizations Market
  • 9.3.3.Japan AAV Contract Development and Manufacturing Organizations Market
  • 9.3.4.Australia AAV Contract Development and Manufacturing Organizations Market
  • 9.3.5.South Korea AAV Contract Development and Manufacturing Organizations Market
  • 9.3.6.Rest of Asia Pacific AAV Contract Development and Manufacturing Organizations Market
• 9.4.Latin America AAV Contract Development and Manufacturing Organizations Market
  • 9.4.1.Brazil AAV Contract Development and Manufacturing Organizations Market
  • 9.4.2.Mexico AAV Contract Development and Manufacturing Organizations Market
  • 9.4.3.Rest of Latin America AAV Contract Development and Manufacturing Organizations Market
• 9.5.Middle East & Africa AAV Contract Development and Manufacturing Organizations Market
  • 9.5.1. Saudi Arabia AAV Contract Development and Manufacturing Organizations Market
  • 9.5.2. South Africa AAV Contract Development and Manufacturing Organizations Market
  • 9.5.3.Rest of Middle East & Africa AAV Contract Development and Manufacturing Organizations Market

Chapter 10.Competitive Intelligence

• 10.1.Key Company SWOT Analysis
• 10.2.Top Market Strategies
• 10.3.Company Profiles
  • 10.3.1. Thermo Fischer Scientific, Inc.
    • 10.3.1.1.1.Key Information
    • 10.3.1.1.2.Overview
    • 10.3.1.1.3.Financial (Subject to Data Availability)
    • 10.3.1.1.4.Product Summary
    • 10.3.1.1.5.Market Strategies
  • 10.3.2. Creative Biogene
  • 10.3.3.Catalent Inc.
  • 10.3.4.Charles River Laboratories International, Inc.
  • 10.3.5. Danaher Corporation
  • 10.3.6.Forge Biologics
  • 10.3.7.Genezen
  • 10.3.8. ViroCell Biologics, Ltd.
  • 10.3.9.Merck KGaA
  • 10.3.10. Viralgen Vector Core S.L.

Chapter 11.Research Process

• 11.1.Research Process
  • 11.1.1.Data Mining
  • 11.1.2.Analysis
  • 11.1.3.Market Estimation
  • 11.1.4.Validation
  • 11.1.5.Publishing
• 11.2.Research Attributes